PMA device
Euclid Orthokeratology (oprifocon A) Contact Lenses for Overnight Wear and Euclid Orthokeratology (tisilfocon A) Contact
Euclid Vision Corporation · Lens, Contact, Orthokeratology, Overnight (NUU, Class III) · First FDA decision Sep 29, 2004, newest Mar 12, 2026Nearsightedness and refractive error
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
11
PMA pathway
Device trials
3
Naming "Euclid"
MAUDE reports
9
Brand "Euclid", since 2015
PubMed studies
260
Mentioning "Euclid"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Euclid Orthokeratology (oprifocon A) Contact Lenses for Overnight Wear and Euclid Orthokeratology (tisilfocon A) Contact
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 11 decisions filed under this name.
- Euclid Orthokeratology (oprifocon A) Contact Lenses for Overnight Wear and Euclid Orthokeratology (tisilfocon A) ContactPMA supplement
P040029-S025 · Decided Mar 12, 2026 · 87 days after receipt · Normal 180 Day Track
Device type: Lens, contact, orthokeratology, overnight (NUU) · Ophthalmology
- Euclid Orthokeratology (oprifocon A) Contact Lenses for Overnight Wear and Euclid Orthokeratology (tisilfocon A) ContactPMA supplement
P040029-S023 · Decided May 23, 2025 · 329 days after receipt · Normal 180 Day Track
Device type: Lens, contact, orthokeratology, overnight (NUU) · Ophthalmology
- Euclid Orthokeratology (oprifocon A) Contact Lenses for Overnight Wear, Euclid Orthokeratology (tisilfocon A) Contact LePMA supplement
P040029-S021 · Decided Mar 6, 2026 · 1,040 days after receipt · Normal 180 Day Track
Device type: Lens, contact, orthokeratology, overnight (NUU) · Ophthalmology
3 more FDA decisions with a free account
Older decisions: P040029-S009, P040029-S006, P040029-S004, P040029-S003, P040029
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Euclid", any status and sponsor, newest update first.
- Euclid Phoenix Lens Design Trial 2Completed
Euclid Systems CorporationNot on our public-company list
NCT06392607 · 89 participants · Start May 28, 2024 · Primary completion Sep 8, 2025
Device: Euclid orthokeratology (standard coating); Euclid orthokeratology (enhanced coating) · For: Myopia; Cornea
Sites: Edina, Minnesota; Sartell, Minnesota; North Brunswick, New Jersey · 5 sites in all
- Euclid Phoenix Lens Design TrialCompleted
Euclid Systems CorporationNot on our public-company list
NCT06389916 · 39 participants · Start Nov 1, 2023 · Primary completion May 9, 2024
Device: Euclid orthokeratology MAX (current design); Euclid orthokeratology MAX Phoenix (new design) · For: Myopia; Cornea
Sites: Costa Mesa, California; Saint Johns, Florida; Edina, Minnesota · 5 sites in all
Xiaoyan YangAcademic, hospital or other
NCT06825585 · 60 participants · Start Jan 1, 2021 · Primary completion Mar 31, 2022
Device: Orthokeratology with 5.0mm back optical zone diameter; Orthokeratology with a 6.2 mm back optical zone diameter · For: Myopia; Myopia; Refractive Error
Sites: Tianjin, China
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Euclid", and for the whole product code for context.
This brand
9 reports: 1 malfunction, 8 injury, 0 death
Whole product code NUU
40 reports: 3 malfunction, 37 injury, 0 death
Newest reports for this brand
3014175039-2026-00003 · Received Aug 10, 2026 · Event dated Jul 9, 2026
Device type: Lens, Contact, Orthokeratology, Overnight (NUU)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Keratitis
3014175039-2026-00002 · Received May 7, 2026 · Event dated Apr 24, 2026
Device type: Lens, Contact, Orthokeratology, Overnight (NUU)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Keratitis
3014175039-2026-00001 · Received Apr 2, 2026 · Event dated Jan 30, 2026
Device type: Lens, Contact, Orthokeratology, Overnight (NUU)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Keratitis
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Euclid"[tiab]. The summary above synthesizes these.
- Divisive language.
Dillon MR · Behav Brain Sci · 2024
- EuCliD--a medical registry.
Steil H, Amato C, Carioni C, et al. · Methods Inf Med · 2004
- EUCLID study.
Tripathi K · Lancet · 1997Comment, Letter
- Understanding Study Drug Discontinuation Through EUCLID.
Weissler EH, Mulder H, Rockhold FW, et al. · Front Cardiovasc Med · 2022
- Efficacy of the Euclid orthokeratology lens in slowing axial elongation.
Bullimore MA, Liu M · Cont Lens Anterior Eye · 2023Review
- Topological Hyperbolic Lattices.
Yu S, Piao X, Park N · Phys Rev Lett · 2020
- Euclid's Random Walk: Developmental Changes in the Use of Simulation for Geometric Reasoning.
Hart Y, Mahadevan L, Dillon MR · Cogn Sci · 2022Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- Elements of successful NIH grant applications.
Araj H, Worth L, Yeung DT · Proc Natl Acad Sci U S A · 2024
- The Euclid Statistical Matrix Tool.
Tilves C, Yekaninejad S, Hayashi T, et al. · Cent Asian J Glob Health · 2017Editorial
- Euclid, Da Vinci and the aortic root.
Sherif HMF · Eur J Cardiothorac Surg · 2019Comment
- Euclid launch: dark-energy mapper poised to probe cosmic mysteries.
Castelvecchi D · Nature · 2023News
- Cleveland, euclid avenue.
Schoenhagen O · Cardiovasc Diagn Ther · 2013
Other devices of this type
Also filed under product code NUU.
- Boston Orthokeratology (oprifocon A) Shaping lens for Overnight Wear for Bausch + Lomb Vision Shaping TreatmentBausch & Lomb · PMA 2025
- Menicon Z Night (tisilfocon A) Contact Lenses for Overnight WearMenicon Co, Ltd. · PMA 2022
- Paragon Z CRT (tisilfocon A) and Paragon Z CRT Dual Axis (tisilfocon A) Rigid Gas Permeable Contact lenses in blue tintCooperVision, Inc. · PMA 2019
- Jsz Orthokeratology (Oprifocon A) Contact Lenses for Overnight WearEuclid Vision Corporation · PMA 2016
- DilightTM (roflufocon E) Overnight Orthokeratology Contact LensTianjin MasterVision Technology Co., Ltd. · PMA 2026
- Optimum Infinite (tisilfocon A) Orthokeratology Lenses IIContamac, Ltd. · PMA 2026
- ACUVUE® Abiliti Overnight and ACUVUE® Abiliti Overnight Therapeutic Lenses for Myopia ManagementMenicon Co, Ltd. · PMA 2021
- Orthokeratology (tisilfocon A) Contact Lenses for Overnight WearEuclid Vision Corporation · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.